Bladder Cancer
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.2 | Q2 | 51.5% | 0.595 | Q2 | 67.3% |
| 2024 | 1.2 | Q3 | 32.8% | 0.324 | Q3 | 48.1% |
| 2023 | 1.0 | Q4 | 24.6% | 0.296 | Q3 | 48.5% |
| 2022 | 1.1 | Q4 | 23.2% | 0.570 | Q2 | 70.4% |
| 2021 | 1.4 | Q4 | 35.3% | 0.544 | Q2 | 69.8% |
| 2020 | — | — | 1.270 | Q1 | 89.9% | |
| 2019 | — | — | 1.088 | Q1 | 87.4% | |
| 2018 | — | — | 1.127 | Q1 | 86.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
2352-3727
ISSN
2352-3735
country
GBcoverage
2015-2024